Clinical Trial Update: rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating recombinant Factor VIIa for intracerebral hemorrhage in patients treated with anticoagulants or antiplatelets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• rFVIIa (recombinant factor VIIa)

Snippet

Sponsor: University Of Perugia | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: UNKNOWN